Clinical trial
Double-blind, Randomized, Placebo-controlled Scientific Study of the Comparative Effectiveness of Fitoavia Dietary Supplement in People With Dyssynchrony Syndrome.
NCT07695870 is registered in ClinicalTrials.gov with MiraxBioPharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Randomized, Placebo-controlled Scientific Study of the Comparative Effectiveness of Fitoavia Dietary Supplement in People With Dyssynchrony Syndrome.
- Lead sponsor
- MiraxBioPharma
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2025
- Completion date
- April 30, 2026
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognition improvement, jet lag, jet lag disorder, jet lag type insomnia